SPDR® S&P Biotech ETF XBI. 0. Company specialized in: Holding Companies. Implied XBI Analyst Target Price: $135. 94 per share, with $121. XBI’s Holdings. com) ReturnsXBI's top 10 holdings account for about 10. 3% over the same period: Image Source: Zacks Investment Research. Its price to cash flow multiples is about 13. 26 during this last 52-week period. BBC vs XBI. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Across the 192 current stocks in the fund, all holdings have a weighting between 0. Top 10 Holdings (14. Only one of these, AbbVie, is a. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. 15 billion assets under management. MTD. AMGN. The fund's investments total to approximately $6. Mirati Therapeutics. There is no guarantee the funds will achieve their stated investment objectives. XBI touched $73. 03 per $1,000 of principal). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. Trades. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 26% rating in the component of Value. XBI's top 10 holdings account for about 11. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. -listed equities in the biotechnology sector. 1% which highlights the scope of the fund and diversification away from company-specific risks. Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite. Per cent of portfolio in top 5 holdings: 8. •. Meanwhile, XBI equal weights its holdings. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. SPDR S&P Biotech ETF Stock Up 1. As of 09/30/2023. 97 and standard deviation of 36. SPDR S&P BIOTECH ETF 87. 97% in the last one year (as of 11/07/2022). Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. The beaten-down prices offer a solid buying opportunity for investors. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. 50(-0. 81 and $97. XBI holdings. Overview. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 6738M. View complete XBI exchange traded fund holdings for better informed ETF trading. 78% in the last one year. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Export data to Excel for your own analysis. 84. 06 and standard deviation of 38. Holdings; Performance; Risk; Performance Overview-12. 56, which is an increase of 43. Historical Price Data. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. 67. N/A. 191), IBB is significantly more concentrated in its top ten holdings than XBI. A few losers won't cause XBI to crash. 35%). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. 01% vs 8. XBI has a beta of 0. Holdings. 01%). More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. Performance and Risk. Holdings AS OF 04/30/2023. 06 as the 52 week high point — that compares with a last trade of $102. XBI, whose index recently expanded, also owns only a handful of established biotech companies. Performance and Risk The ETF has lost about -3. SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. Top 10 Holdings 16. 2. Holdings AS OF 04/30/2023. This index comprises companies in the biotech industry that are a part of the S&P Total Market Index. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Skip to main content. argenx SE ADR. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. The top holding in XBI receives just a 1. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. 01%). (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. Cryptocurrency. LABU has a lower 5-year return than XBI (-46. XBI: SPDR® S&P Biotech ETF: 1. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. 80% of total assets under management. It has a total of 153 holdings. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. View complete WCLD exchange traded fund holdings for better informed ETF trading. 08 per unit, that means that analysts see 59. Performance and Risk The ETF has lost about -29. In addition to holding 155 positions, its top 10 holdings make up just 14. Site search Search. Download as Image. 12 and $91. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). 1. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Below is the comparison between FBT and XBI. The index and exchange-traded fund ETF are rebalanced four times a year. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. XBI, whose index recently expanded, also owns only a handful of established biotech companies. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. 4% of the stocks in our database. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. For an investor to take. The fund’s NAV was $81. Nov 20, 2023Top 10 Holdings. Currency in USD Follow 2W 10W 9M 72. To make the peptide traceable, it was radiolabeled with the long. 09%: Canada: 1. MRTX. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. **Close price adjusted for splits and dividend and/or capital gain distributions. The XBI broke out in Q3 2016 and again in June 2017. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 35% vs 0. 5. 01%). The top 10 holdings account for about 11. 73. 15 billion. Monday's ETF Movers: XBI, QCLN. Learn everything about iShares Biotechnology ETF (IBB). View the latest ETF prices and news for better ETF investing. 35%. 40. XBI's 120. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. ETF Summary. 79 as the 52 week high point — that compares with a last trade of $159. Looking at the chart above, XBI's low point in its 52 week range is $72. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). 9. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Implied XBI Analyst Target Price: $135. Advertisement. Further, the fund owns $6. FA Report PDF. 80 per share, with $92. 85. Jun 23, 2022 10:49AM EDT. SPDR S&P Biotech ETF ETF holdings by MarketWatch. Both ARKG and XBI are ETFs. It can be found in the fund’s most recent prospectus. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. Warren Buffett is known for holding onto his S&P 500 stocks forever. 15%: Country Percentage; United States: 94. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. The fund's investments total to approximately $6. Reply Like (7) q. 10 as of November 2, 2022. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Holdings. 57 billion. XBI has a beta of 0. XBI has traded between $62. 45% vs 0. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). Staples:. 78% of XBI's total assets under management. The split for XBI took place on September 11, 2015. Additionally. 2013. Again, top 10 holdings. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. So far this year, XBI has lost about -5. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. 2% weight, and there are 133 holdings in total in the fund (Figure 1). In XBI, the top five holdings together represent only 9. Meanwhile, XBI equal weights its holdings. According to data from U. IBB's and XBI's Top Holdings are About to Break Out. Fund Size Comparison. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. This major support zone runs from $101. Asset type. , including minimum market capitalization and. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol. 86% so far this year and is down about -32. Holdings. 250-590-1718. The XBI index methodology takes market cap and share liquidity into account in rebalancing holdings. 06 as the 52 week high point — that compares with a last trade of $109. 18. 86% so far this year and is down about -32. 47% vs -5. 9. Stocks. Currency in USD Follow 2W 10W 9M 73. 1% vs 0. 04 per unit, that means that analysts see 73. 06 a share on Wednesday which marked its lowest level dating back to June 30 of 2022. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. 96%, and is down about -5. February 15, 2023 — 10:47 am EST. 7042%). Market Capitalization. The beaten-down prices offer a solid buying opportunity for investors. Thu, Nov 9, 1:16 PM ET, Market News Video. The stock holdings of the XBI tends to be re. 69% allocation. 60 as the 52 week high point — that compares with a last trade of $77. Royal Gold Inc. 7. 79 in February 2021 and has fallen over (50%) to $76. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. Currency in USD. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 27%. 10(-0. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. 15 billion. 94 per share, with $121. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 01%). XBI is suitable for investors seeking to. XBI Looks. XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. At midday the XBI is rebounding indicating there is buying interest near $101. Over a longer time than that, it has no top holdings. 06 as the 52 week high point — that compares with a last trade of $109. 97. VHT has a lower expense ratio than XBI (0. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. Looking at the chart above, XBI's low point in its 52 week range is $63. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Brazil. Shares of XBI stock opened at $73. 51 on Tuesday. 32% Category Average 45. Company Change % Net. XBI Holdings5 Beaten-Down ETFs to Buy Now. 00. Holding Companies. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. For an ETF, this widget displays the top 10 constituents that make up the fund. View Holdings As of 09/30/2023. Written by BNK Invest for BNK Invest ->. $6. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. , and Amgen Inc. $36. It is gross of any fee waivers or expense reimbursements. Both LABU and XBI are ETFs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Looking at the chart above, XBI's low point in its 52 week range is $62. The Health category average is 45. With about 156 holdings, it effectively. . 50 down to $98. Again, top 10 holdings. 2015. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at , one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. News & World Report, XBI enjoys volume of 20. No single stock makes up even 1% of XBI's overall holdings. This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. 00%) Most Recent Dividend 0. 93% of its total assets under management. VHT has a higher 5-year return than XBI (7. 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. 19%. It's trading down (17%) versus LABU, down (68%) in one-year performance. 9%. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. The weighted harmonic average of closing market price divided by. 58. 1. We have highlighted five ETFs from different. Themes & Subsectors ETFs. SPDR S&P Biotech ETF ETF holdings by MarketWatch. Summary. According to data from U. 28% IONS Ionis Pharmaceuticals Inc Biotechnology. Total healthcare and life sciences M&A was about $71. Looking at the chart above, XBI's low point in its 52 week range is $62. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. View Holdings As of 08/31/2023. View complete XLV exchange traded fund holdings for better informed ETF trading. View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). 78% so far this year and in the past one year (as of 11/20/2023), respectively. NEW: Experience our best charts yet. 5% year-to-date and 38. -listed equities in the biotechnology sector. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. ETF. VHT has a higher 5-year return than XBI (7. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. 1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. IBB vs. 78% of XBI's total assets under management. There are a number of factors behind this strategy, the overriding one being that biotech has pulled back in the fall a large percentage of the. But that definitely wasn't the case recently. NAV as of Nov 09, 2023. The following charts reflect the geographic spread of WCLD's underlying holdings. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. View complete XBI exchange traded fund holdings for better informed ETF trading. Name Symbol % Assets. 16bn USD. Complete SPDR S&P Biotech ETF funds overview by Barron's. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. Looking at the chart above, XBI's low point in its 52 week range is $115. 35% for XBI, but SBIO yields 2. Both FBT and XBI are ETFs. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. FBT has a higher expense ratio than XBI (0. 264,458,476. Further, the fund owns $6. Looking at the chart above, XBI's low point in its 52 week range is $100. Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron (REGN). As a result, the ETF reached a new 8-month low. 65%. Performance. Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006. 1% and 1. 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. Fund Analysis. Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. Looking at the chart above, XBI's low point in its 52 week range is $62. Its top 10 holdings account for approximately 16. US. Holdings. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. Feel free to the browse the list and view the comparisons that are of an interest to you. 0. ARGX. Top Holdings . currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. Trade XBI with: Price/Earnings ttm 17. The top holding in XBI receives just a 1. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. The fee is slightly higher for SBIO - . This is based on the percent of the fund this stock's assets represent. 66 +2. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U. Chart. The top 10 holdings account for about 10. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"),. No company usually makes up more than two percent of. The big biotech. Shares of Amgen , IBB's top holding with a weight of 8. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. 15 per share, with $174. It can be found in the fund’s most recent prospectus. Performance and Risk The ETF has lost about -9. SPDR® S&P Biotech ETF XBI: NYSE Arca . ETF Strategies. 20. Immunovant Inc. $0. 8% of its total assets under management. Quote. (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. 12% in the last one year (as of 03/16/2023). The company has an 88. N/A. Like IBB, XBI uses diversification to. XBI is suitable for investors seeking to. The. 95. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). $72. 94 per share, with $107. With XBI trading at a recent price near $122.